New Delhi, August 12, 2020.
Russia has delivered on its promise to develop the world’s first vaccine for novel Coronavirus. On Tuesday, it announced that it had approved a vaccine being developed by Moscow’s Gamaleya Institute. The announcement has been met with excitement as well as skepticism due to the fact that the vaccine has been cleared without phase-3 human trials. Even the phase-1 and phase-2 trials have been rushed, all of it being completed within two months.
However, it still might be some distance away from becoming generally accessible, especially to people outside Russia. The vaccine is likely to get into production immediately. Apart from the facility at the Gamaleya Institute itself, it is supposed to be manufactured by Sistema, a big Russian business house. In a statement on Tuesday, Sistema said the first batches of the vaccine were ready, and would be shortly shipped to Russian provinces to be administered first to doctors and healthcare workers who are at high risk of infection.